On Tuesday, Biocon Ltd. said its unit has received approval from the US health regulator for a genetic anti-bacterial medication. The approval was given to Biocon’s unit in partnership with Carnegie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback